Masahiro Ohira

1.7k total citations
64 papers, 1.3k citations indexed

About

Masahiro Ohira is a scholar working on Surgery, Cardiology and Cardiovascular Medicine and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Masahiro Ohira has authored 64 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Surgery, 29 papers in Cardiology and Cardiovascular Medicine and 25 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Masahiro Ohira's work include Cardiovascular Health and Disease Prevention (19 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (16 papers) and Diet and metabolism studies (9 papers). Masahiro Ohira is often cited by papers focused on Cardiovascular Health and Disease Prevention (19 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (16 papers) and Diet and metabolism studies (9 papers). Masahiro Ohira collaborates with scholars based in Japan, Australia and China. Masahiro Ohira's co-authors include Atsuhito Saiki, Kei Endo, Daiji Nagayama, Kohji Shirai, Takashi Yamaguchi, Yoh Miyashita, Tomokazu Oyama, Hidetoshi Kawana, Noriko Ban and Ichiro Tatsuno and has published in prestigious journals such as Blood, Scientific Reports and European Heart Journal.

In The Last Decade

Masahiro Ohira

59 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Masahiro Ohira Japan 23 761 438 334 211 186 64 1.3k
Kei Endo Japan 24 653 0.9× 417 1.0× 324 1.0× 239 1.1× 158 0.8× 84 1.4k
Tomokazu Oyama Japan 21 649 0.9× 422 1.0× 396 1.2× 228 1.1× 179 1.0× 36 1.3k
Daiji Nagayama Japan 21 1.0k 1.4× 451 1.0× 267 0.8× 209 1.0× 118 0.6× 67 1.5k
Shigemasa Tani Japan 24 480 0.6× 592 1.4× 309 0.9× 177 0.8× 223 1.2× 129 1.7k
Simona Marchesi Italy 21 904 1.2× 419 1.0× 469 1.4× 230 1.1× 206 1.1× 43 2.0k
Natale Vazzana Italy 19 549 0.7× 218 0.5× 346 1.0× 160 0.8× 218 1.2× 31 1.5k
Graziana Lupattelli Italy 22 558 0.7× 464 1.1× 346 1.0× 266 1.3× 218 1.2× 80 1.5k
Jobien K. Olijhoek Netherlands 13 552 0.7× 332 0.8× 354 1.1× 177 0.8× 101 0.5× 21 1.2k
Takayuki Ise Japan 21 756 1.0× 321 0.7× 228 0.7× 266 1.3× 280 1.5× 94 1.5k
Jang‐Ho Bae South Korea 21 1.2k 1.6× 894 2.0× 272 0.8× 174 0.8× 132 0.7× 99 2.1k

Countries citing papers authored by Masahiro Ohira

Since Specialization
Citations

This map shows the geographic impact of Masahiro Ohira's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Masahiro Ohira with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Masahiro Ohira more than expected).

Fields of papers citing papers by Masahiro Ohira

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Masahiro Ohira. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Masahiro Ohira. The network helps show where Masahiro Ohira may publish in the future.

Co-authorship network of co-authors of Masahiro Ohira

This figure shows the co-authorship network connecting the top 25 collaborators of Masahiro Ohira. A scholar is included among the top collaborators of Masahiro Ohira based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Masahiro Ohira. Masahiro Ohira is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nagayama, Daiji, Yasuhiro Watanabe, Kohji Shirai, Masahiro Ohira, & Atsuhito Saiki. (2025). Modified Metabolic Syndrome Criteria Considering Cardio-Ankle Vascular Index (CAVI) and A Body Shape Index (ABSI): Implications for Kidney Risk. Reviews in Cardiovascular Medicine. 26(3). 26583–26583. 1 indexed citations
2.
Shimizu, Seiichi, Shintaro Kuroda, Ryosuke Nakano, et al.. (2025). Durvalumab induced immune-related agranulocytosis after conversion surgery in a patient with intrahepatic cholangiocarcinoma: a case report. Frontiers in Immunology. 16. 1610190–1610190.
3.
Awaya, Toru, et al.. (2023). Graves’ Disease after mRNA COVID-19 Vaccination, with the Presence of Autoimmune Antibodies Even One Year Later. Vaccines. 11(5). 934–934. 9 indexed citations
4.
Yamaguchi, Takashi, Satoshi Morimoto, Atsuhiro Ichihara, et al.. (2023). Soluble (Pro)Renin Receptor Level in Patients with Severe Obesity Is Associated with Visceral Adiposity and Is Involved with Insulin Resistance and Renal Injury. Obesity Facts. 16(4). 335–343. 1 indexed citations
5.
Ohira, Masahiro, Yasuhiro Watanabe, Takashi Yamaguchi, et al.. (2021). The Relationship between Serum Insulin-Like Growth Factor-1 Levels and Body Composition Changes after Sleeve Gastrectomy. Obesity Facts. 14(6). 641–649. 3 indexed citations
6.
Yamaguchi, Takashi, Masahiro Ohira, Shoko Nakamura, et al.. (2021). High presepsin concentrations in bile and its marked elevation in biliary tract diseases: A retrospective analysis. Clinica Chimica Acta. 521. 278–284. 4 indexed citations
7.
Ohira, Masahiro, Yasuhiro Watanabe, Takashi Yamaguchi, et al.. (2021). Decreased Triglyceride and Increased Serum Lipoprotein Lipase Levels Are Correlated to Increased High-Density Lipoprotein-Cholesterol Levels after Laparoscopic Sleeve Gastrectomy. Obesity Facts. 14(6). 633–640. 1 indexed citations
8.
Watanabe, Yasuhiro, Takashi Yamaguchi, Kazuki Abe, et al.. (2021). Effect of Conventional Medical Therapy or Laparoscopic Sleeve Gastrectomy on Urinary Albumin in Japanese Subjects with Severe Obesity: An Observational Study. Obesity Facts. 14(6). 613–621. 2 indexed citations
9.
Ohira, Masahiro, Yasuhiro Watanabe, Takashi Yamaguchi, et al.. (2021). Determinants of type 2 diabetes remission after bariatric surgery in obese Japanese patients: a retrospective cohort study. Diabetology International. 12(4). 379–388. 4 indexed citations
10.
Watanabe, Yasuhiro, Daisuke Suzuki, Nobuichi Kuribayashi, et al.. (2021). A randomized controlled trial of two diets enriched with protein or fat in patients with type 2 diabetes treated with dapagliflozin. Scientific Reports. 11(1). 11350–11350. 5 indexed citations
11.
Nagayama, Daiji, Atsuhito Saiki, Yasuhiro Watanabe, et al.. (2021). Prevention of Cardiovascular Events with Pitavastatin is Associated with Increased Serum Lipoprotein Lipase Mass Level: Subgroup Analysis of the TOHO-LIP. Journal of Atherosclerosis and Thrombosis. 29(4). 451–463. 4 indexed citations
12.
Saiki, Atsuhito, Shoko Nakamura, Sho Tanaka, et al.. (2020). Impact of Mental Health Background and Nutrition Intake on Medium-Term Weight Loss in Japanese Patients Undergoing Laparoscopic Sleeve Gastrectomy. Obesity Facts. 13(4). 371–383. 6 indexed citations
13.
Ohira, Masahiro, Takashi Yamaguchi, Atsuhito Saiki, et al.. (2019). Laparoscopic Sleeve Gastrectomy Significantly Increases Serum Lipoprotein Lipase Level in Obese Patients. Obesity Facts. 12(3). 357–368. 10 indexed citations
14.
Ohira, Masahiro, Takashi Yamaguchi, Noriko Ban, et al.. (2014). Metformin reduces circulating malondialdehyde-modified low-density lipoprotein in type 2 diabetes mellitus. Clinical and investigative medicine. 37(4). E243–E251. 12 indexed citations
15.
Shirai, Kohji, Atsuhito Saiki, Kei Endo, et al.. (2013). Evaluation of Blood Pressure Control using a New Arterial Stiffness Parameter, Cardio-ankle Vascular Index (CAVI). Current Hypertension Reviews. 9(1). 66–75. 43 indexed citations
16.
Endo, Kei, Atsuhito Saiki, Takashi Yamaguchi, et al.. (2013). Probucol Suppresses Initiation of Chronic Hemodialysis Therapy and Renal Dysfunction-Related Death in Diabetic Nephropathy Patients: Sakura Study. Journal of Atherosclerosis and Thrombosis. 20(5). 494–502. 18 indexed citations
17.
Ohira, Masahiro, Kei Endo, Atsuhito Saiki, et al.. (2012). Atorvastatin and pitavastatin enhance lipoprotein lipase production in L6 skeletal muscle cells through activation of adenosine monophosphate-activated protein kinase. Metabolism. 61(10). 1452–1460. 23 indexed citations
18.
Saiki, Atsuhito, Masahiro Ohira, Kei Endo, et al.. (2009). Circulating angiotensin II is associated with body fat accumulation and insulin resistance in obese subjects with type 2 diabetes mellitus. Metabolism. 58(5). 708–713. 63 indexed citations
19.
Saiki, Atsuhito, Masahiro Ohira, Kei Endo, et al.. (2006). The angiotensin II receptor antagonist valsartan enhances lipoprotein lipase mass in preheparin serum in type 2 diabetes with hypertension. Diabetes Research and Clinical Practice. 74(3). 242–248. 14 indexed citations
20.
Orime, Yukihiko, T. Hasegawa, Shinzo Kitamura, et al.. (1989). [Multiple organ failure following open heart surgery in adults].. PubMed. 9(3). 246–51.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026